Clinical reports have recently suggested that l-norepinephrine is a valuable agent in the treatment of shock (1) (2) (3) . It has been found relatively more effective in those cases in which there is no major decrease in blood volume, such as in shock due to drug sensitivity, myocardial infarction, overwhelming infection and post-operative hypotension unresponsive to transfusion. Also, some cases of surgical or oligemic shock are reported in which it has been used with success (4) (5) (6) . The rationale for the use of l-norepinephrine in shock rests on the observation that its administration is followed by restoration of blood pressure and general clinical improvement. However, since there is a body of surgical opinion which holds that pressor drugs are contraindicated in the treatment of hemorrhagic hypotension, the present series of experiments was designed to define the circulatory responses of the dog to l-norepinephrine during graded hemorrhage. Cardiac output, arterial pressure and total peripheral resistance were the parameters measured.
The effects of l-norepinephrine on the normal human circulation are well known (7) . The drug elicts a bradycardia, an increase in systolic and diastolic arterial pressures, an increase in total peripheral resistance, a slight decrease or no change in cardiac output, an increase in coronary blood flow, a marked decrease in renal, cutaneous, skeletal muscular and cerebral blood flows and no change of estimated splanchnic blood flow (7) . From these circulatory responses, it is apparent that coronary and hepatic blood flow are maintained or increased under the influence of 1-norepinephrine, while flow in other vascular cir-cuits is decreased. Current experimental evidence places the blame for the development of irreversible surgical shock on failure of the liver and heart. If l-norepinephrine given to the shocked animal also produces relative increases of flow through these two (10) . The base line for arterial pressure was taken at the skin of the back of the dog.
Experimental hemorrhagic shock was produced by the two-stage bleeding technique described by Wiggers (11) . After the animals had been anesthetized and all apparatus was in satisfactory working order, two determinations of cardiac output, pulse rate, central venous and arterial pressures were made in close sequence. L-norepinephrine 4was then administered intravenously by a constant infusion pump for ten minutes after which time the same determinations were repeated. (This series of determinations constitute the control period.) The l-norepinephrine infusion was then discontinued. After arterial pressure had returned to the base line level, bleeding was begun by syringe at a rate of 50 ml. per min. and continued until a pressure of 50 mm. Hg was reached. This level was maintained for several minutes. Another set of deter- (Table III) , in no instance is the rise statistically significant.
During experiments 1 to 9, right atrial pressure was measured. In the control period 1-norepinephrine caused a rise of mean right atrial pressure (2.8 mm. Hg to 4.1 mim. Hg), which is not significant (p = .12). There was no change of mean auricular pressure during the remaining stages of the experiment.
DISCUSSION
The increase in mean arterial pressure observed in response to l-norepinephrine during the control period has been widely reported (7) . Other observers have also noted the variation of response of cardiac output to the drug (7, 12 Brewster, Isaacs, and Waino-Andersen (12) and Zanetti and Opdyke (13) A preparation has recently been devised with which changes of venous return and of available circilating blood volume may be demonstrated (15) . Blood is diverted from the inferior and superior venae cavae into a reservoir from which blood is returned to the right heart. In this preparation (in the dog) injections of 1-norepinephrine caused an increase of venous return and eight per cent sustained increment of blood in the reservoir.
During the irreversible stage of shock, in which l-norepinephrine was not effective in increasing cardiac output, venoconstriction was probably at a minimum due to a complete loss of venous responsiveness. If l-norepinephrine does play a direct role in stimulating the heart and effecting an increase of cardiac output, it is perhaps due to an increased coronary flow (16) and hence improved myocardial metabolism.
The preparation employed results in 82 per cent mortality after the end of the second stage of hemorrhage, and death within six hours after the reinfusion of the total volume shed (11) . Therefore, the failure to demonstrate significant increases in cardiac output and arterial pressure during the late two stages of shock can be attributed to the condition of the animals at this time.
The increase of peripheral resistance occurring after hemorrhage is a well-known phenomenon. Remington Possible reasons for the lack of rise in peripheral resistance during the control are discussed above. In the earlier stages of hemorrhage, the pressure rise effected by l-norepinephrine was accompanied by elevations of cardiac output. Late in hemorrhage neither cardiac output nor pressure increased.
The validity of the single dye injection method for determining cardiac output during hemorrhage in the dog is discussed by Hamilton and Remington (18) . Others have compared this method with the direct Fick technique over a wide range of conditions and outputs in man (19) .
The results of these experiments complement clinical observations of the effect of 1-norepinephrine in oligemic shock. During the early stages of hemorrhagic hypotension when blood volume has not been critically depleted, and during severe hemorrhage prior to the development of irreversibility, the drug effected significant increases in cardiac output and arterial pressure. Moreover, during the experiments, the drug caused no adverse effects. After near fatal exsanguination or peripheral vascular failure, however, 1-norepinephrine was of little therapeutic value. The above results would seem to justify the further clinical investigation of the effects of l-norepinephrine in the treatment of oligemic shock pending, or as an adjunct to, whole blood transfusion. The temporary relief afforded by the drug during hemorrhagic hypotension may have significant applications in the treatment of surgical cases provided it is clearly realized that whole blood transfusion is still the primary therapy of oligemic shock.
SUMMARY AND CONCLUSIONS
In experimental hemorrhagic hypotension in dogs, 1-norepinephrine (0.75 u per min. per Kg.) elicits significant increases of cardiac output and arterial pressure. Later in hemorrhage and after the development of irreversible shock, 1-norepinephrine effects no significant change of arterial pressure or cardiac output. During no stage of hemorrhagic hypotension did the drug elicit an increase of total peripheral resistance.
